» Articles » PMID: 30865893

P53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake

Overview
Journal Cell Rep
Publisher Cell Press
Date 2019 Mar 14
PMID 30865893
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells heavily depend on the amino acid glutamine to meet the demands associated with growth and proliferation. Due to the rapid consumption of glutamine, cancer cells frequently undergo glutamine starvation in vivo. We and others have shown that p53 is a critical regulator in metabolic stress resistance. To better understand the molecular mechanisms by which p53 activation promotes cancer cell adaptation to glutamine deprivation, we identified p53-dependent genes that are induced upon glutamine deprivation by using RNA-seq analysis. We show that Slc7a3, an arginine transporter, is significantly induced by p53. We also show that increased intracellular arginine levels following glutamine deprivation are dependent on p53. The influx of arginine has minimal effects on known metabolic pathways upon glutamine deprivation. Instead, we found arginine serves as an effector for mTORC1 activation to promote cell growth in response to glutamine starvation. Therefore, we identify a p53-inducible gene that contributes to the metabolic stress response.

Citing Articles

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets.

Nan D, Yao W, Huang L, Liu R, Chen X, Xia W Cell Commun Signal. 2025; 23(1):45.

PMID: 39856712 PMC: 11760113. DOI: 10.1186/s12964-024-02018-6.


A hormetic response model for glutamine stress in cancer.

Grenier S, Commisso C Trends Cancer. 2024; 11(3):196-203.

PMID: 39681506 PMC: 11903170. DOI: 10.1016/j.trecan.2024.11.008.


Targeting cellular adaptive responses to glutaminolysis perturbation for cancer therapy.

Kim M, Hwang S, Jeong S Mol Cells. 2024; 47(8):100096.

PMID: 39038517 PMC: 11342766. DOI: 10.1016/j.mocell.2024.100096.


Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer.

Yoo Y, Quan S, Yang W, Guo Q, Rodriguez Y, Chalmers Z Cancer Res. 2024; 84(18):3004-3022.

PMID: 38959335 PMC: 11405136. DOI: 10.1158/0008-5472.CAN-23-2910.


References
1.
Maddocks O, Berkers C, Mason S, Zheng L, Blyth K, Gottlieb E . Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 2012; 493(7433):542-6. PMC: 6485472. DOI: 10.1038/nature11743. View

2.
Qing G, Li B, Vu A, Skuli N, Walton Z, Liu X . ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell. 2012; 22(5):631-44. PMC: 3510660. DOI: 10.1016/j.ccr.2012.09.021. View

3.
Ye J, Palm W, Peng M, King B, Lindsten T, Li M . GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes Dev. 2015; 29(22):2331-6. PMC: 4691887. DOI: 10.1101/gad.269324.115. View

4.
Wang S, Tsun Z, Wolfson R, Shen K, Wyant G, Plovanich M . Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science. 2015; 347(6218):188-94. PMC: 4295826. DOI: 10.1126/science.1257132. View

5.
Itahana Y, Itahana K . Emerging Roles of p53 Family Members in Glucose Metabolism. Int J Mol Sci. 2018; 19(3). PMC: 5877637. DOI: 10.3390/ijms19030776. View